Board Changes - Jonathan Fleming (4242Q)

TIDMATD

RNS Number : 4242Q

Asterand PLC

19 October 2011

 
 For Immediate Release   19 October 2011

Asterand plc

("Asterand" or the "Company")

Board Changes

The Company wishes to announce that Jonathan Fleming, a Non Executive Director, has resigned from the Board with immediate effect.

Jack Davis, the Chairman and Interim CEO, said: "The Board would like to thank Jonathan for his contribution over the last few years and we wish him well for the future."

Contacts:

 
 Asterand plc 
 Jack Davis, Chairman and Interim Chief   Tel: + 44 (0) 1763 211 600 / + 
  Executive Officer                        1 (313) 263-0960 
 Alan Fishman, Interim Chief Financial    As above 
  Officer 
 
 Buchanan Communications 
 Lisa Baderoon / Mark Court / Isabel      Tel: +44 (0) 20 7466 5000 
  Podda 
 
 Daniel Stewart & Company plc 
 Antony Legge                             Tel: +44 (0) 20 7776 6550 
 Martin Lampshire

About Asterand

Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market. For more information about Asterand, go to www.asterand.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOALLFVTIRLTLIL

Bioseek (LSE:ATD)
Historical Stock Chart
From Jun 2024 to Jul 2024